Ureido-type sulfamate and benzenesulfonamide CAIX/XII inhibitors are screened for the potential to inhibit the tumour-associated hCAIX/XII isoforms over the off-target hCAI/II isoforms. The gene discussed is CYP24A1; the disease is neoplasm.